The interactions between the PD‐1 receptor on T cells and its ligand PD‐L1 on tumour cells induce T cell exhaustion,7 and antibodies targeting PD‐1/PD‐L1 signalling can boost the endogenous anti‐tumour immunity.8 The gene discussed is CD274; the disease is neoplasm.